Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART.
about
Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia:Prevalence of Anemia and Immunological Markers in HIV-Infected Patients on Highly Active Antiretroviral Therapy in Northeastern Nigeria.Magnitude of cytopenias among HIV-infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART-experienced childrenHIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and ZimbabweDiagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis.Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia.Evaluating the utility of early laboratory monitoring of antiretroviral-induced haematological and hepatic toxicity in HIV-infected persons in Cameroon.Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010.Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, EthiopiaCurrent practices in laboratory monitoring of HIV infection.A non-specific biomarker of disease activity in HIV/AIDS patients from resource-limited environments.Prevalence, severity, and related factors of anemia in HIV/AIDS patients.Impact of HIV Infection and Zidovudine Therapy on RBC Parameters and Urine Methylmalonic Acid Levels.Magnitude and correlates of moderate to severe anemia among adult HIV patients receiving first line HAART in Northwestern Tanzania: a cross sectional clinic based studyDevelopment of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral RegimensScreening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy.Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon.Anemia among adult HIV patients in Ethiopia: a hospital-based cross-sectional study.A Study of Alternate Biomarkers in HIV Disease and Evaluating their Efficacy in Predicting T CD4+ Cell Counts and Disease Progression in Resource Poor Settings in Highly Active Antiretroviral Therapy (HAART) Era.Magnitude of Anemia and Associated Factors among Pediatric HIV/AIDS Patients Attending Zewditu Memorial Hospital ART Clinic, Addis Ababa, Ethiopia.Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study.Prevalence of anemia before and after initiation of antiretroviral therapy among HIV infected patients at Black Lion Specialized Hospital, Addis Ababa, Ethiopia: a cross sectional study.Staging and haematological abnormalities of HIV-infected persons in Mangaung in the Free State Province, South Africa.
P2860
Q33414194-425C109F-007A-41DE-A091-AA69D89F4C55Q33415421-F563400A-43B0-462C-A430-66B0F9E39629Q33439843-E2F4146F-2676-4960-90DD-6AEB91A4EC3BQ33713765-12CA8E37-30CC-4EA6-A637-C3C6F215A5EFQ33755986-FF9DB16C-0E7C-4AA3-9BBD-3FAED01C50DDQ34251519-94D12EC7-CC34-43DC-9779-084CDE433CB5Q34670487-B12D270B-DD94-4544-AD7F-A6399C8E7C52Q34973660-730ABDB2-9113-4039-9764-97F0600627EFQ35110406-DA4DFDCF-5E09-4006-A0E7-00F157F4BEC4Q35653517-B859A7EF-11AB-48DA-96A1-0D10F9977F69Q35770853-D558EA7B-562F-42A2-98AB-0D97C9D388A7Q35780654-F744CE00-E36C-4827-9FD0-DE0535B92483Q36474615-95BD3C12-6ECA-46AE-A9DA-639E980423BEQ36637546-39FCAE1F-66BC-46FB-9152-825D2B2D7B95Q36869155-750D12C2-9D80-4E73-AEAD-7DD3B63A5F9BQ37094829-ACF32863-6067-4C91-A500-8B898D9FBFB1Q37151342-EC250353-1810-4553-A99A-BE9F01042F00Q37182021-3940F1A2-7824-4B56-8D95-589F1A15A2C8Q37579676-76F094E4-F6FA-4E1B-A74F-E9ED55FC1203Q37652858-28B75D26-22EC-4CE8-958D-64CAB0D605CFQ38405243-1D37D660-0CAF-40B7-B9B1-DE0DDB55A9D9Q39328455-3CD53793-B0CF-49C4-A027-42A74A806C2DQ47553147-860D0B48-67E4-4286-8943-39A6E9ACEC1EQ51736260-06CC8D1B-0253-48AD-B378-98A517C2543DQ54541052-DD6ACF19-8FA9-4DC6-84E6-37681FEA15FC
P2860
Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prevalence of anaemia and immu ...... V-patients and those on HAART.
@ast
Prevalence of anaemia and immu ...... V-patients and those on HAART.
@en
Prevalence of anaemia and immu ...... V-patients and those on HAART.
@nl
type
label
Prevalence of anaemia and immu ...... V-patients and those on HAART.
@ast
Prevalence of anaemia and immu ...... V-patients and those on HAART.
@en
Prevalence of anaemia and immu ...... V-patients and those on HAART.
@nl
prefLabel
Prevalence of anaemia and immu ...... V-patients and those on HAART.
@ast
Prevalence of anaemia and immu ...... V-patients and those on HAART.
@en
Prevalence of anaemia and immu ...... V-patients and those on HAART.
@nl
P2093
P2860
P1476
Prevalence of anaemia and immu ...... IV-patients and those on HAART
@en
P2093
O Addai-Mensah
W K B A Owiredu
P2860
P577
2011-03-01T00:00:00Z